Reference
Huang G, et al. Nivolumab plus gemcitabine, dexamethasone, and cisplatin chemotherapy induce durable complete remission in relapsed/refractory primary mediastinal B-cell lymphoma: a case report and literature review. Journal of International Medical Research 48: No. 8, 01 Aug 2020. Available from: URL: http://doi.org/10.1177/0300060520945075
Rights and permissions
About this article
Cite this article
Antineoplastics. Reactions Weekly 1821, 34 (2020). https://doi.org/10.1007/s40278-020-83154-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-020-83154-5